True Wealth Design, LLC Sage Therapeutics, Inc. Transaction History
True Wealth Design, LLC
- $263 Billion
- Q1 2025
A detailed history of True Wealth Design, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, True Wealth Design, LLC holds 781 shares of SAGE stock, worth $5,045. This represents 0.0% of its overall portfolio holdings.
Number of Shares
781
Previous 36
2069.44%
Holding current value
$5,045
Previous $196,000
3067.86%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SAGE
# of Institutions
218Shares Held
50MCall Options Held
220KPut Options Held
312K-
Black Rock Inc. New York, NY5.22MShares$33.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$32.8 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY4.48MShares$28.9 Million4.6% of portfolio
-
Tig Advisors, LLC New York, NY2.73MShares$17.7 Million1.36% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.09MShares$13.5 Million0.02% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $384M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...